Shibeikang Biopharmaceutical

China
Chengdu, Sichuan, China

Company profile

Shibeikang Biopharmaceutical company profile

Shibeikang Biopharmaceutical is a high-tech enterprise dedicated to the differentiated and innovative research and development of new drugs, aiming to address unmet medical needs through advanced biotechnology, precision medicine, and cutting-edge pharmaceutical innovation.

Business identity

Operating status
Active
Company type
For Profit
Founded
2015-01-01, Year

Headquarters

Country code
CN
Continent
Asia

Capital profile

Funding and company signals

Funding stage
Early Stage Venture
Funding rounds
1
Total equity funding
$14M
Last funding
Series B / $14M / 2025-08-27
Last equity funding
Series B / $14M
Investors
1
Lead investors
1

Categories and groups

No public categories are available.

Founders and investors

Lead investors

Chengda Pharmaceutical

Investors

Chengda Pharmaceutical